Finally, $ETST also plans to raise $2.5 million for future clinical studies, the addition of new product lines, to meet production requirements, to purchase inventory, and for general working capital. In total, the Company plans to raise an aggregate of $4 million pursuant to its planned offering, for which it will seek SEC qualification under Tier II of Regulation A+.